Bayer submits application for next indication of Kerendia in China
July 30, 2026
July 30, 2026
LEVERKUSEN, Germany, July 30 [Category: BizPharmaceuticals] -- Bayer Group, a pharmaceutical and life sciences company, posted the following news release:
* * *
Bayer submits application for next indication of Kerendia in China
*
Berlin, July 30, 2026 - Bayer today announced the submission of a New Drug Application to the Center of Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA), seeking approval to extend . . .
* * *
Bayer submits application for next indication of Kerendia in China
*
Berlin, July 30, 2026 - Bayer today announced the submission of a New Drug Application to the Center of Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA), seeking approval to extend . . .